Abstract
Objective: Epidemiologic data relating obesity to risk of colorectal cancer in women have been inconclusive. Two recent studies have suggested that the association may be modified by estrogen status; BMI was positively associated with colorectal cancer risk among women with high estrogen exposures [premenopausal women, and postmenopausal women who currently received postmenopausal hormone therapy (PMH)]. We prospectively investigated the role of BMI in colorectal cancer risk along with the modifying effects of estrogen in a large cohort from the Women's Health Study.
Methods: Among 39,876 apparently healthy women aged ≥45 years at baseline (54% of them were postmenopausal), 37,671 were eligible for the present study. During an average of 8.7 years of follow-up, 202 women had a confirmed diagnosis of colorectal cancer. Baseline BMI was calculated by dividing self-reported weight in kilograms by height in meters squared.
Results: The multivariate relative risks (RRs) and 95% confidence interval (CI) of colorectal cancer were 1.72 (1.12–2.66) for 27–29.9 kg/m2, and 1.67 (1.08–2.59) for ≥30 kg/m2, as compared with BMI < 23 kg/m2(p for trend = 0.02). This positive association was seen primarily in the proximal colon (p for trend = 0.004). When the association was further examined according to PMH use among postmenopausal women, we found that both current and never users with higher BMI were at a greater risk of colorectal cancer (p for interaction between BMI and PMH use = 0.33). As compared with BMI <23 kg/m2, the multivariate RRs and 95% CI for 27–29.9 and ≥30 kg/m2 were 1.98 (0.98–3.99) and 1.41 (0.65–3.06) among current users, and 1.05 (0.42–2.65) and 2.91 (1.40–6.06) among never users.
Conclusions: These data suggest that higher BMI was associated with an elevated risk of colorectal cancer, and the positive relationship was not altered by estrogen exposure among postmenopausal women.
Similar content being viewed by others
References
Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ (2003) Cancer statistics, 2003. CA Cancer J Clin 53(1): 5–26.
Boyle P, Langman JS (2000) ABC of colorectal cancer: epidemiology. BMJ 321(7264): 805–808.
McKeown-Eyssen G (1994) Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev 3 (8)}: 687–695.
Giovannucci E (1995) Insulin and colon cancer. Cancer Causes Control 6(2): 164–179.
Giovannucci E (2002) Obesity, gender, and colon cancer. Gut 51(2): 147.
Garfinkel L (1985) Overweight and cancer. Ann Intern Med 103 (6 ( Pt 2)): 1034–1036.
Gerhardsson M, Steineck G, Norell SE (1990) Colorectal cancer in Sweden. A descriptive epidemiologic study. Acta Oncol 29(7): 855–861.
Kune GA, Kune S, Watson LF (1990) Body weight and physical activity as predictors of colorectal cancer risk. Nutr Cancer 13(1–2): 9–17.
Le Marchand L, Wilkens LR, Mi MP (1992) Obesity in youth and middle age and risk of colorectal cancer in men. Cancer Causes Control 3(4): 349–354.
Slattery ML, Potter J, Caan B, et al. (1997) Energy balance and colon cancer-beyond physical activity. Cancer Res 57(1): 75–80.
Chyou PH, Nomura AM, Stemmermann GN (1996) A prospective study of colon and rectal cancer among Hawaii Japanese men. Ann Epidemiol 6(4): 276–282.
Russo A, Franceschi S, La Vecchia C, et al.(1998) Body size and colorectal-cancer risk. Int J Cancer 78(2): 161–165.
Caan BJ, Coates AO, Slattery ML, Potter JD, Quesenberry Jr. CP, Edwards SM (1998) Body size and the risk of colon cancer in a large case-control study. Int J Obes Relat Metab Disord 22(2): 178–184.
Murphy TK, Calle EE, Rodriguez C, Kahn HS, Thun MJ (2000) Body mass index and colon cancer mortality in a large prospective study. Am J Epidemiol 152(9): 847–854.
Nomura A, Heilbrun LK, Stemmermann GN (1985) Body mass index as a predictor of cancer in men. J Natl Cancer Inst 74(2): 319–323.
Lee IM, Paffenbarger Jr. RS, (1992) Quetelet's index and risk of colon cancer in college alumni. J Natl Cancer Inst 84(17): 1326–1331.
Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH (1992) Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med 327(19): 1350–1355.
Giovannucci E, Rimm EB, Ascherio A, Stampfer MJ, Colditz GA, Willett WC (1995) Alcohol, low-methionine-low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst 87(4): 265–273.
Shimizu N, Nagata C, Shimizu H, et al. (2003) Height, weight, and alcohol consumption in relation to the risk of colorectal cancer in Japan: a prospective study. Br J Cancer 88(7): 1038–1043.
West DW, Slattery ML, Robison LM, et al. (1989) Dietary intake and colon cancer: sex-and anatomic site-specific associations. Am J Epidemiol 130(5): 883–894.
Bostick RM, Potter JD, Kushi LH, et al. (1994) Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States). Cancer Causes Control 5(1): 38–52.
Phillips RL, Snowdon DA (1985) Dietary relationships with fatal colorectal cancer among Seventh-Day Adventists. J Natl Cancer Inst 74(2): 307–317.
Chute CG, Willett WC, Colditz GA, Stampfer MJ, Rosner B, Speizer FE. (1991) A prospective study of reproductive history and exogenous estrogens on the risk of colorectal cancer in women. Epidemiology 2(3): 201–207.
Thun MJ, Calle EE, Namboodiri MM, et al. (1992) Risk factors for fatal colon cancer in a large prospective study. J Natl Cancer Inst 84(19): 1491–1500.
Howe GR, Aronson KJ, Benito E, et al. (1997) The relationship between dietary fat intake and risk of colorectal cancer: evidence from the combined analysis of 13 case-control studies. Cancer Causes Control 8(2): 215–228.
Martinez ME, Giovannucci E, Spiegelman D, Hunter DJ, Willett WC, Colditz GA (1997) Leisure-time physical activity, body size, and colon cancer in women. Nurses' Health Study Research Group. J Natl Cancer Inst 89(13): 948–955.
Le Marchand L, Wilkens LR, Kolonel LN, Hankin JH, Lyu LC (1997) Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. Cancer Res 57(21): 4787–4794.
Wu AH, Paganini-Hill A, Ross RK, Henderson BE (1987) Alcohol, physical activity and other risk factors for colorectal cancer: a prospective study. Br J Cancer 55(6): 687–694.
Bird CL, Frankl HD, Lee ER, Haile RW (1998) Obesity, weight gain, large weight changes, and adenomatous polyps of the left colon and rectum. Am J Epidemiol 147(7)}: 670–6
Terry P, Giovannucci E, Bergkvist L, Holmberg L, Wolk A (2001) Body weight and colorectal cancer risk in a cohort of Swedish women: relation varies by age and cancer site. Br J Cancer 85(3): 346–349.
Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348(17): 1625–1638.
Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD (2002) Postmenopausal hormone replacement therapy: scientific review. JAMA 288(7)}: 872–8
Terry PD, Miller AB, Rohan TE (2002) Obesity and colorectal cancer risk in women. Gut 51(2): 191–194.
Slattery ML, Ballard-Barbash R, Edwards S, Caan BJ, Potter JD (2003) Body mass index and colon cancer: an evaluation of the modifying effects of estrogen (United States). Cancer Causes Control 14(1): 75–84.
Dietz AT, Newcomb PA, Marcus PM, Storer BE (1995) The association of body size and large bowel cancer risk in Wisconsin (United States) women. Cancer Causes Control 6(1): 30–36.
McCashland TM, Brand R, Lyden E, de Garmo P (2001) Gender differences in colorectal polyps and tumors. Am J Gastroenterol 96(3): 882–886.
Ikeda Y, Koyanagi N, Mori M, et al. (1996) ncreased incidence of proximal colon cancer in the elderly. J Clin Gastroenterol 23(2): 105–108.
Miller A, Gorska M, Bassett M (2000) Proximal shift of colorectal cancer in the Australian Capital Territory over 20 years. Aust N Z J Med 30(2): 221–225.
Rexrode KM, Lee IM, Cook NR, Hennekens CH, Buring JE (2000) Baseline characteristics of participants in the Women's Health Study. J Womens Health Gend Based Med 9(1): 19–27.
Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC (1992) Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 135(10): 1114–1126; discussion 1127-36._
Romieu I, Willett WC, Stampfer MJ, et al. (1988) Energy intake and other determinants of relative weight. Am J Clin Nutr 47(3): 406–412.
Landis RJ, Heyman ER, Koch GG (1978) Average partial association in three-way contingency tables: a review and discussion of alternative tests. Int Statist Rev 46: 237–254.
Bock RD (1975) Multivariate Statistical Methods in Behavioral Research. New York: McGraw-Hill.
Koohestani N, Tran TT, Lee W, Wolever TM, Bruce WR (1997) Insulin resistance and promotion of aberrant crypt foci in the colons of rats on a high-fat diet. Nutr Cancer 29(1): 69–76.
Khaw KT, Barrett-Connor E (1984) Systolic blood pressure and cancer mortality in an elderly population. Am J Epidemiol 120(4): 550–558.
Trichopoulou A, Tzonou A, Hsieh CC, Toupadaki N, Manousos O, Trichopoulos D (1992) High protein, saturated fat and cholesterol diet, and low levels of serum lipids in colorectal cancer. Int J Cancer 51(3): 386–389.
Kono S, Honjo S, Todoroki I, et al. (1998) Glucose intolerance and adenomas of the sigmoid colon in Japanese men (Japan). Cancer Causes Control 9(4): 441–446.
Schoen RE, Tangen CM, Kuller LH, et al. (1999) Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst 91(13): 1147–1154.
Kaaks R, Toniolo P, Akhmedkhanov A, et al. (2000) Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 92(19): 1592–1600.
Colangelo LA, Gapstur SM, Gann PH, Dyer AR, Liu K (2002) Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev 11(4): 385–391.
Lahm H, Suardet L, Laurent PL, et al. (1992) Growth regulation and co-stimulation of human colorectal cancer cell lines by insulinlike growth factor I, II and transforming growth factor alpha. Br J Cancer 65(3): 341–346.
Remacle-Bonnet M, Garrouste F, el Atiq F, Roccabianca M, Marvaldi J, Pommier G (1992) des-(1–3)-IGF-I, an insulin-like growth factor analog used to mimic a potential IGF-II autocrine loop, promotes the differentiation of human colon-carcinoma cells. Int J Cancer 52(6): 910–917.
Wu Y, Yakar S, Zhao L, Hennighausen L, LeRoith D (2002) Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis. Cancer Res 62(4): 1030–1035.
Grimberg A, Cohen P (2000) Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol 183(1): 1–9.
Komninou D, Ayonote A, Richie Jr. JP, Rigas B (2003) Insulin resistance and its contribution to colon carcinogenesis. Exp Biol Med (Maywood) 228(4): 396–405.
Kelley KM, Oh Y, Gargosky SE, et al. (1996) Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochem Cell Biol 28(6): 619–637.
Ma J, Pollak MN, Giovannucci E, et al. (1999) Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 91(7): 620–625.
Manousos O, Souglakos J, Bosetti C, et al. (1999) IGF-I and IGFII in relation to colorectal cancer. Int J Cancer83(1): 15–17.
Giovannucci E, Pollak MN, Platz EA, et al. (2000) A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers Prev 9(4): 345–349.
Slattery ML, Anderson K, Curtin K, et al. (2001) Lifestyle factors and Ki-ras mutations in colon cancer tumors. Mutat Res 483(1–2): 73–81.
Lynch HT, de la Chapelle A (2003) Hereditary colorectal cancer. N Engl J Med 348(10): 919–932.
Slattery ML, Potter JD, Curtin K, et al. (2001) Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer. Cancer Res 61(1): 126–130.
Daws MR, Westley BR, May FE (1996) Paradoxical effects of overexpression of the type I insulin-like growth factor (IGF) receptor on the responsiveness of human breast cancer cells to IGFs and estradiol. Endocrinology 137(4): 1177–1186.
Molloy CA, May FE, Westley BR (2000) Insulin receptor substrate-1 expression is regulated by estrogen in the MCF-7 human breast cancer cell line. J Biol Chem 275(17): 12565–12571.
Murphy LJ, Friesen HG (1988) Differential effects of estrogen and growth hormone on uterine and hepatic insulin-like growth factor I gene expression in the ovariectomized hypophysectomized rat. Endocrinology 122(1): 325–332.
Manson JE, Willett WC, Stampfer MJ, et al. (1995) Body weight and mortality among women. N Engl J Med 333(11): 677–685.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lin, J., Zhang, S.M., Cook, N.R. et al. Body Mass Index and Risk of Colorectal Cancer in Women (United States). Cancer Causes Control 15, 581–589 (2004). https://doi.org/10.1023/B:CACO.0000036168.23351.f1
Issue Date:
DOI: https://doi.org/10.1023/B:CACO.0000036168.23351.f1